Eric Lev

Eric Lev currently serves as a Board Member for BIOLOGOS and multiple healthcare companies including P95, iuvo BioScience, Biosynth, ALPCO, and Resolian. As a General Partner at Ampersand Capital Partners since February 2013, Eric Lev focuses on growth-oriented healthcare investments. Eric Lev has held various board membership positions, including past roles at Leinco Technologies and Interpace Biosciences. Eric Lev earned an MBA from The University of Chicago Booth School of Business and a BA in Economics from Northwestern University, in addition to graduating from Belmont Hill School.